Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ongun Onaran

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Trends in Pharmacological Sciences|June 27, 2002
The ligand paradox between affinity and efficacy: can you be there and not make a difference?Terry Kenakin, Ongun Onaran
Cellular Signalling|March 21, 2021
Biased agonism at G protein-coupled receptorsKarim Nagi, H Ongun Onaran
Handbook of Experimental Pharmacology|September 13, 2025
Biased Agonism at β-Adrenoceptor Subtypes: A Drug Development PerspectiveMartin C Michel, Ongun Onaran
British Journal of Pharmacology|February 12, 2024
Why classical receptor theory, which ignores allostery, can effectively measure the strength of an allosteric effect as agonist's efficacyH Ongun Onaran, Tommaso Costa
Current Protein & Peptide Science|April 10, 2009
Allosteric coupling and conformational fluctuations in proteinsH Ongun Onaran, Tommaso Costa
Trends in Pharmacological Sciences|July 3, 1999
Ligand efficacy and affinity in an interacting 7TM receptor modelH Ongun Onaran, H Gürdal
Cellular Signalling|February 19, 2021
Conceptual and experimental issues in biased agonismH Ongun Onaran, Tommaso Costa
Nature Chemical Biology|July 20, 2012
Where have all the active receptor states gone?H Ongun Onaran, Tommaso Costa
British Journal of Pharmacology|May 16, 2002
Agonist-directed trafficking explaining the difference between response pattern of naratriptan and sumatriptan in rabbit common carotid arteryDemet Akin, H Ongun Onaran, Hakan Gurdal
Trends in Pharmacological Sciences|December 3, 2014
What is biased efficacy? Defining the relationship between intrinsic efficacy and free energy couplingH Ongun Onaran, Sudarshan Rajagopal, Tommaso Costa
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Trends in Pharmacological Sciences|June 27, 2002
The ligand paradox between affinity and efficacy: can you be there and not make a difference?Terry Kenakin, Ongun Onaran
Cellular Signalling|March 21, 2021
Biased agonism at G protein-coupled receptorsKarim Nagi, H Ongun Onaran
Handbook of Experimental Pharmacology|September 13, 2025
Biased Agonism at β-Adrenoceptor Subtypes: A Drug Development PerspectiveMartin C Michel, Ongun Onaran
British Journal of Pharmacology|February 12, 2024
Why classical receptor theory, which ignores allostery, can effectively measure the strength of an allosteric effect as agonist's efficacyH Ongun Onaran, Tommaso Costa
Current Protein & Peptide Science|April 10, 2009
Allosteric coupling and conformational fluctuations in proteinsH Ongun Onaran, Tommaso Costa
Trends in Pharmacological Sciences|July 3, 1999
Ligand efficacy and affinity in an interacting 7TM receptor modelH Ongun Onaran, H Gürdal
Cellular Signalling|February 19, 2021
Conceptual and experimental issues in biased agonismH Ongun Onaran, Tommaso Costa
Nature Chemical Biology|July 20, 2012
Where have all the active receptor states gone?H Ongun Onaran, Tommaso Costa
British Journal of Pharmacology|May 16, 2002
Agonist-directed trafficking explaining the difference between response pattern of naratriptan and sumatriptan in rabbit common carotid arteryDemet Akin, H Ongun Onaran, Hakan Gurdal
Trends in Pharmacological Sciences|December 3, 2014
What is biased efficacy? Defining the relationship between intrinsic efficacy and free energy couplingH Ongun Onaran, Sudarshan Rajagopal, Tommaso Costa
Pageof 2